Literature DB >> 11943209

Autotaxin promotes motility via G protein-coupled phosphoinositide 3-kinase gamma in human melanoma cells.

Hoi Young Lee1, Gyu Un Bae, In Duk Jung, Jang Soon Lee, Yong Kee Kim, Sung Hoon Noh, Mary L Stracke, Chang Gyo Park, Hyang Woo Lee, Jeung Whan Han.   

Abstract

Autotaxin (ATX), an exo-nucleotide pyrophosphatase and phosphodiesterase, stimulates tumor cell motility at sub-nanomolar levels and augments invasiveness and angiogenesis. We investigated the role of G protein-coupled phosphoinositide 3-kinase gamma (PI3Kgamma) in ATX-mediated tumor cell motility stimulation. Pretreatment of human melanoma cell line A2058 with wortmannin or LY294002 inhibited ATX-induced motility. ATX increased the PI3K activity in p110gamma, but not p85, immunoprecipitates. This effect was abrogated by PI3K inhibitors or inhibited by pertussis toxin. Furthermore, stimulation of tumor cell motility by ATX was inhibited by catalytically inactive form of PI3Kgamma, strongly indicating the crucial role of PI3Kgamma for ATX-mediated motility in human melanoma cells

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11943209     DOI: 10.1016/s0014-5793(02)02457-2

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  9 in total

Review 1.  Roles of Autotaxin/Autotaxin-Lysophosphatidic Acid Axis in the Initiation and Progression of Liver Cancer.

Authors:  Sha She; Qian Zhang; Jinzhi Shi; Fan Yang; Kai Dai
Journal:  Front Oncol       Date:  2022-06-13       Impact factor: 5.738

2.  Autotaxin is released from adipocytes, catalyzes lysophosphatidic acid synthesis, and activates preadipocyte proliferation. Up-regulated expression with adipocyte differentiation and obesity.

Authors:  Gilles Ferry; Edwige Tellier; Anne Try; Sandra Grés; Isabelle Naime; Marie Françoise Simon; Marianne Rodriguez; Jérémie Boucher; Ivan Tack; Stéphane Gesta; Pascale Chomarat; Marc Dieu; Martine Raes; Jean Pierre Galizzi; Philippe Valet; Jean A Boutin; Jean Sébastien Saulnier-Blache
Journal:  J Biol Chem       Date:  2003-03-17       Impact factor: 5.157

3.  Identification of small-molecule inhibitors of autotaxin that inhibit melanoma cell migration and invasion.

Authors:  Lauren P Saunders; Amy Ouellette; Russ Bandle; William Chozen Chang; Hongwen Zhou; Raj N Misra; Enrique M De La Cruz; Demetrios T Braddock
Journal:  Mol Cancer Ther       Date:  2008-10       Impact factor: 6.261

Review 4.  Autotaxin (ATX): a multi-functional and multi-modular protein possessing enzymatic lysoPLD activity and matricellular properties.

Authors:  Larra M Yuelling; Babette Fuss
Journal:  Biochim Biophys Acta       Date:  2008-04-29

5.  In vitro anti-inflammatory and pro-aggregative effects of a lipid compound, petrocortyne A, from marine sponges.

Authors:  Sungyoul Hong; Sung Hwan Kim; Man Hee Rhee; Ae Ra Kim; Jee H Jung; Taehoon Chun; Eun Sook Yoo; Jae Youl Cho
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-11-13       Impact factor: 3.000

6.  Autotaxin: its role in biology of melanoma cells and as a pharmacological target.

Authors:  Maciej Jankowski
Journal:  Enzyme Res       Date:  2011-03-08

7.  Stat3 mediates expression of autotaxin in breast cancer.

Authors:  Janeen Azare; Ashley Doane; Kenneth Leslie; Qing Chang; Marjan Berishaj; Jennifer Nnoli; Kevin Mark; Hikmat Al-Ahmadie; William Gerald; Maryam Hassimi; Agnes Viale; Mary Stracke; David Lyden; Jacqueline Bromberg
Journal:  PLoS One       Date:  2011-11-28       Impact factor: 3.240

Review 8.  KAI1/CD82 gene and autotaxin-lysophosphatidic acid axis in gastrointestinal cancers.

Authors:  Shuo Wang; Jiang Chen; Xiao-Zhong Guo
Journal:  World J Gastrointest Oncol       Date:  2022-08-15

Review 9.  The emerging role of FTY720 (Fingolimod) in cancer treatment.

Authors:  Christopher White; Heba Alshaker; Colin Cooper; Matthias Winkler; Dmitri Pchejetski
Journal:  Oncotarget       Date:  2016-04-26
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.